Ignyte Acquisition Corp. (IGNY)
|Net Income (ttm)||n/a|
|Trading Day||April 19|
|Day's Range||9.78 - 9.88|
|52-Week Range||9.58 - 9.98|
NEW YORK--(BUSINESS WIRE)--Ignyte Acquisition Corp. (NASDAQ: IGNYU) (the “Company”) announced today that, commencing on or about March 12, 2021, holders of its units sold in the Company's initial public...
NEW YORK--(BUSINESS WIRE)--Ignyte Acquisition Corp. (NASDAQ: IGNYU) (the “Company”) announced that it closed its initial public offering of 5,750,000 units, including the full 750,000 units subject to t...
CORRECTING and REPLACING Ignyte Acquisition Corp. Announces Pricing of $50,000,000 Initial Public Offering
NEW YORK--(BUSINESS WIRE)--First paragraph, first sentence of release dated January 27, 2021 should read: Ignyte Acquisition Corp. (NASDAQ:IGNYU) (the “Company”) announced today that it priced its initi...
NEW YORK--Ignyte Acquisition Corp. (NASDAQ:IGNYU) (the “Company”) announced today that it priced its initial public offering of 50,000,000 units at $10.00 per unit. The units will be listed on the Nasda...
Ignyte Acquisition, a blank check company formed by Ladenburg Thalman executives targeting the life sciences, biotechnology and healthcare sectors, filed on Monday with the SEC to raise up to $50 millio...
Ignyte Acquisition Corp. has filed to go public with an IPO on the NASDAQ.
Ignyte Acquisition was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. We may pursue a business combination opportunity in any business or industry we choose although we currently intend to focus on target companies in the life sciences, biotechnology and healthcare sectors. We are led by our Chairman and Co-Chief Executive Officer, David Rosenberg, who is the Co-Chief Executive Off... [Read more...]
|IPO Date |
Jan 28, 2021
David Rosenberg and David J. Strupp, Jr.
|Stock Exchange |
|Ticker Symbol |